New breed of VCs banking on biotech
New breed of VCs banking on biotech
As the era of rock-star venture capitalists investing in Internet start-ups appears to be ending, another era is dawning — one of VCs flocking into biotech and health care.
New breed of VCs banking on biotech
As the era of rock-star venture capitalists investing in Internet start-ups appears to be ending, another era is dawning — one of VCs flocking into biotech and health care.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!